Prolytix, formerly Haematologic Technologies, has 30+ years of experience in protein chemistry, which ensures our team will identify and solve the challenges of your large molecule product. 

Our services in research and development, characterization by high-resolution mass spectrometry (HRMS), GxP testing, and custom collection devices assist clients worldwide. Using an agile, consultative approach, we support your product’s development from discovery through GMP release. With our proven CMC and regulatory expertise from IND through BLA to our accessible, attentive, and seasoned team, Prolytix is the go-to partner for protein therapeutic projects from routine to complex. For advanced protein development, go with the pro — Prolytix. 

To learn more about our expertise, services, and products, visit GoProlytix.com. 

Biotechnology

Life Sciences

Medical Devices

Pharmaceutical

Research

Therapeutics

Prolytix

David Halverson

Lyndsey O'Brien

John Moriarity

Matthew F. Whelihan

Richard Pouliot

Jamie Connelly

Ryan Dorfman

The Leadership Team at Prolytix is responsible for setting the strategic direction, driving business growth, and ensuring operational excellence across the organization. This team leverages its extensive expertise in protein chemistry, regulatory affairs, and business development to guide the company in delivering advanced protein therapeutic solutions from discovery through GMP release. The team's consultative approach ensures that clients receive attentive and knowledgeable support for their complex projects.

Leadership Team

Business Development

Quality Control Team

Leadership Team

About

Team members

Other teams at Prolytix

Business Development

Quality Control Team